Search
for
Sort by
Research 271–300 of 1000+
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- EXPERIENCE OF A PRIVATE HOSPITAL IN THE FEDERAL DISTRICT IN CRYOTHERAPY WITH A HYPOTHERMAL CAP FOR PATIENTS USING PACLITAXEL 80 MG/M² WEEKLY FOR 12 WEEKS
- Index
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- Adverse effect profile with low-dose methotrexate therapy in patients suffering with rheumatic diseases
- No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
- Proinflammatory Event of Ozonized Olive Oil in Mice
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Sunscreen: Cosmetic or medical therapy?
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Effects of local and systemic medications on eye health: Adverse reactions
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- A Retrospective Study on the Safety of Systemic Minoxidil for Hair Loss in the Older Population
- Drug-induced hair colour changes
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Side effects of low-dose oral minoxidil for treating alopecia
- Topoisomerase‐Interacting Agents
- TRANSMEDCON 2022: E-Poster Abstracts